| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 8.01e-14 | 5 | 50 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 4.80e-13 | 6 | 50 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | chloride ion binding | 3.43e-10 | 16 | 50 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | calcium ion binding | AMY1A AMY1B AMY1C AMY2A AMY2B NRXN1 SLIT1 PLSCR3 CHORDC1 DNAH7 FBN3 SVEP1 | 2.33e-07 | 749 | 50 | 12 | GO:0005509 |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 5.84e-06 | 103 | 50 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 2.97e-05 | 144 | 50 | 5 | GO:0016798 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of T cell polarity | 3.44e-05 | 4 | 50 | 2 | GO:1903905 | |
| Domain | Aamy_C | 4.18e-11 | 4 | 49 | 4 | SM00632 | |
| Domain | Alpha_amylase | 4.18e-11 | 4 | 49 | 4 | IPR006046 | |
| Domain | Alpha-amylase_C | 2.09e-10 | 5 | 49 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 2.09e-10 | 5 | 49 | 4 | IPR006048 | |
| Domain | Aamy | 1.45e-09 | 7 | 49 | 4 | SM00642 | |
| Domain | Alpha-amylase | 1.45e-09 | 7 | 49 | 4 | PF00128 | |
| Domain | Glyco_hydro_13_cat_dom | 1.45e-09 | 7 | 49 | 4 | IPR006047 | |
| Domain | A-amylase_C | 1.70e-08 | 3 | 49 | 3 | IPR031319 | |
| Domain | Glyco_hydro_b | 5.59e-08 | 15 | 49 | 4 | IPR013780 | |
| Domain | Glyco_hydro_13 | 3.38e-07 | 6 | 49 | 3 | IPR015902 | |
| Domain | Glyco_hydro_catalytic_dom | 2.89e-06 | 38 | 49 | 4 | IPR013781 | |
| Domain | - | 6.05e-06 | 14 | 49 | 3 | 2.60.40.1180 | |
| Domain | Glycoside_hydrolase_SF | 1.11e-05 | 53 | 49 | 4 | IPR017853 | |
| Domain | KRAB | 3.85e-05 | 358 | 49 | 7 | PS50805 | |
| Domain | KRAB | 3.85e-05 | 358 | 49 | 7 | PF01352 | |
| Domain | KRAB | 4.67e-05 | 369 | 49 | 7 | SM00349 | |
| Domain | KRAB | 4.75e-05 | 370 | 49 | 7 | IPR001909 | |
| Domain | hEGF | 5.31e-05 | 28 | 49 | 3 | PF12661 | |
| Domain | - | 1.05e-04 | 35 | 49 | 3 | 3.20.20.80 | |
| Domain | - | 1.12e-04 | 95 | 49 | 4 | 2.60.120.200 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.71e-04 | 106 | 49 | 4 | IPR000152 | |
| Domain | EGF | 3.31e-04 | 126 | 49 | 4 | PF00008 | |
| Domain | - | 3.53e-04 | 679 | 49 | 8 | 3.30.160.60 | |
| Domain | zf-C2H2 | 4.05e-04 | 693 | 49 | 8 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 4.09e-04 | 694 | 49 | 8 | IPR013087 | |
| Domain | Laminin_G | 4.73e-04 | 58 | 49 | 3 | IPR001791 | |
| Domain | ZINC_FINGER_C2H2_2 | 8.45e-04 | 775 | 49 | 8 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 8.59e-04 | 777 | 49 | 8 | PS00028 | |
| Domain | Znf_C2H2-like | 1.00e-03 | 796 | 49 | 8 | IPR015880 | |
| Domain | Znf_C2H2 | 1.08e-03 | 805 | 49 | 8 | IPR007087 | |
| Domain | ZnF_C2H2 | 1.11e-03 | 808 | 49 | 8 | SM00355 | |
| Domain | EGF_Ca-bd_CS | 2.10e-03 | 97 | 49 | 3 | IPR018097 | |
| Domain | EGF_CA | 2.23e-03 | 99 | 49 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.30e-03 | 100 | 49 | 3 | PS00010 | |
| Domain | ConA-like_dom | 2.58e-03 | 219 | 49 | 4 | IPR013320 | |
| Domain | EGF_3 | 3.32e-03 | 235 | 49 | 4 | PS50026 | |
| Domain | EGF | 3.32e-03 | 235 | 49 | 4 | SM00181 | |
| Domain | EGF_CA | 4.02e-03 | 122 | 49 | 3 | SM00179 | |
| Domain | EGF-like_dom | 4.08e-03 | 249 | 49 | 4 | IPR000742 | |
| Domain | EGF-like_Ca-bd_dom | 4.21e-03 | 124 | 49 | 3 | IPR001881 | |
| Domain | EGF_1 | 4.44e-03 | 255 | 49 | 4 | PS00022 | |
| Domain | LAM_G_DOMAIN | 4.46e-03 | 38 | 49 | 2 | PS50025 | |
| Domain | EGF-like_CS | 4.82e-03 | 261 | 49 | 4 | IPR013032 | |
| Domain | Laminin_G_2 | 4.94e-03 | 40 | 49 | 2 | PF02210 | |
| Domain | EGF_2 | 5.09e-03 | 265 | 49 | 4 | PS01186 | |
| Domain | LamG | 5.95e-03 | 44 | 49 | 2 | SM00282 | |
| Domain | Growth_fac_rcpt_ | 7.95e-03 | 156 | 49 | 3 | IPR009030 | |
| Domain | zf-C2H2_6 | 9.17e-03 | 314 | 49 | 4 | PF13912 | |
| Domain | SCAN | 9.49e-03 | 56 | 49 | 2 | SM00431 | |
| Domain | SCAN_BOX | 1.02e-02 | 58 | 49 | 2 | PS50804 | |
| Domain | SCAN | 1.02e-02 | 58 | 49 | 2 | PF02023 | |
| Domain | SCAN_dom | 1.02e-02 | 58 | 49 | 2 | IPR003309 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 1.02e-11 | 9 | 36 | 5 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 3.72e-11 | 11 | 36 | 5 | M1091 | |
| Pathway | REACTOME_DIGESTION | 2.65e-09 | 23 | 36 | 5 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 7.66e-09 | 28 | 36 | 5 | M27837 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.94e-07 | 52 | 36 | 5 | M14171 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 8.49e-07 | 8 | 36 | 3 | MM14717 | |
| Pathway | REACTOME_DIGESTION | 1.97e-05 | 21 | 36 | 3 | MM15526 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 3.38e-05 | 25 | 36 | 3 | MM15557 | |
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 3.00e-14 | 6 | 50 | 5 | 6608795 | |
| Pubmed | 3.00e-14 | 6 | 50 | 5 | 2081604 | ||
| Pubmed | 3.00e-14 | 6 | 50 | 5 | 15286789 | ||
| Pubmed | 3.00e-14 | 6 | 50 | 5 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 3.00e-14 | 6 | 50 | 5 | 2788608 | |
| Pubmed | 2.79e-13 | 8 | 50 | 5 | 12414807 | ||
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 3.78e-12 | 4 | 50 | 4 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 3.78e-12 | 4 | 50 | 4 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 3.78e-12 | 4 | 50 | 4 | 6166922 | |
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 3.78e-12 | 4 | 50 | 4 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 3.78e-12 | 4 | 50 | 4 | 6163812 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 3.78e-12 | 4 | 50 | 4 | 26098870 | |
| Pubmed | 3.78e-12 | 4 | 50 | 4 | 6160849 | ||
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 3.78e-12 | 4 | 50 | 4 | 2987507 | |
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 3.78e-12 | 4 | 50 | 4 | 4745489 | |
| Pubmed | 3.78e-12 | 4 | 50 | 4 | 6091898 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 3.78e-12 | 4 | 50 | 4 | 1141004 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 3.78e-12 | 4 | 50 | 4 | 94264 | |
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 3.78e-12 | 4 | 50 | 4 | 2332419 | |
| Pubmed | 3.78e-12 | 4 | 50 | 4 | 3872721 | ||
| Pubmed | 3.78e-12 | 4 | 50 | 4 | 6157477 | ||
| Pubmed | 3.78e-12 | 4 | 50 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 3.78e-12 | 4 | 50 | 4 | 6162108 | |
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 3.78e-12 | 4 | 50 | 4 | 2431276 | |
| Pubmed | 3.78e-12 | 4 | 50 | 4 | 16152770 | ||
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 3.78e-12 | 4 | 50 | 4 | 6207174 | |
| Pubmed | 3.78e-12 | 4 | 50 | 4 | 2423416 | ||
| Pubmed | 3.78e-12 | 4 | 50 | 4 | 2410924 | ||
| Pubmed | 3.78e-12 | 4 | 50 | 4 | 2476716 | ||
| Pubmed | 3.78e-12 | 4 | 50 | 4 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 3.78e-12 | 4 | 50 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 3.78e-12 | 4 | 50 | 4 | 2989529 | |
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 1.89e-11 | 5 | 50 | 4 | 8661735 | |
| Pubmed | 1.89e-11 | 5 | 50 | 4 | 6529441 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 1.89e-11 | 5 | 50 | 4 | 34276419 | |
| Pubmed | 1.89e-11 | 5 | 50 | 4 | 6176569 | ||
| Pubmed | 1.89e-11 | 5 | 50 | 4 | 1348427 | ||
| Pubmed | 5.66e-11 | 6 | 50 | 4 | 7946325 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 5.66e-11 | 6 | 50 | 4 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 5.66e-11 | 6 | 50 | 4 | 284003 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 5.66e-11 | 6 | 50 | 4 | 7859283 | |
| Pubmed | 5.66e-11 | 6 | 50 | 4 | 2002257 | ||
| Pubmed | 5.66e-11 | 6 | 50 | 4 | 2450406 | ||
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 5.66e-11 | 6 | 50 | 4 | 9250879 | |
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 5.66e-11 | 6 | 50 | 4 | 1021597 | |
| Pubmed | 1.32e-10 | 7 | 50 | 4 | 6160178 | ||
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 1.32e-10 | 7 | 50 | 4 | 1401878 | |
| Pubmed | 1.32e-10 | 7 | 50 | 4 | 8604219 | ||
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 1.32e-10 | 7 | 50 | 4 | 2451911 | |
| Pubmed | 1.32e-10 | 7 | 50 | 4 | 8666240 | ||
| Pubmed | 1.32e-10 | 7 | 50 | 4 | 7949740 | ||
| Pubmed | 2.63e-10 | 8 | 50 | 4 | 2824476 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 2.63e-10 | 8 | 50 | 4 | 6200103 | |
| Pubmed | 2.63e-10 | 8 | 50 | 4 | 8486361 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 2.63e-10 | 8 | 50 | 4 | 7523515 | |
| Pubmed | 2.63e-10 | 8 | 50 | 4 | 2040456 | ||
| Pubmed | 2.63e-10 | 8 | 50 | 4 | 3038891 | ||
| Pubmed | 4.74e-10 | 9 | 50 | 4 | 93520 | ||
| Pubmed | 7.88e-10 | 10 | 50 | 4 | 9121556 | ||
| Pubmed | 7.88e-10 | 10 | 50 | 4 | 2897103 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 1.24e-09 | 11 | 50 | 4 | 7493641 | |
| Pubmed | 1.24e-09 | 11 | 50 | 4 | 23449223 | ||
| Pubmed | Four loci from human chromosome 1 are physically assigned to sheep chromosome 1p. | 1.24e-09 | 11 | 50 | 4 | 8589528 | |
| Pubmed | 1.24e-09 | 11 | 50 | 4 | 2903254 | ||
| Pubmed | 1.24e-09 | 11 | 50 | 4 | 2565740 | ||
| Pubmed | 1.24e-09 | 11 | 50 | 4 | 7608209 | ||
| Pubmed | 1.24e-09 | 11 | 50 | 4 | 1617215 | ||
| Pubmed | 1.85e-09 | 12 | 50 | 4 | 8144363 | ||
| Pubmed | Assignment of the mouse homologues of 6 loci from HSA1p to chromosomes 3 and 4. | 2.68e-09 | 13 | 50 | 4 | 7829080 | |
| Pubmed | 2.68e-09 | 13 | 50 | 4 | 489953 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 15299664 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 32697825 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 2.80e-09 | 3 | 50 | 3 | 2413838 | |
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 6098446 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 12527308 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 2414282 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 8413315 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 28659346 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 2.80e-09 | 3 | 50 | 3 | 21827821 | |
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 30982860 | ||
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 2.80e-09 | 3 | 50 | 3 | 6360562 | |
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 22063648 | ||
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 2.80e-09 | 3 | 50 | 3 | 2436036 | |
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 1699843 | ||
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 2.80e-09 | 3 | 50 | 3 | 6180955 | |
| Pubmed | An insulin-responsive element in the pancreatic enhancer of the amylase gene. | 2.80e-09 | 3 | 50 | 3 | 7678001 | |
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 25588701 | ||
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 2.80e-09 | 3 | 50 | 3 | 17223109 | |
| Pubmed | 3.74e-09 | 14 | 50 | 4 | 2902233 | ||
| Pubmed | 3.74e-09 | 14 | 50 | 4 | 7894156 | ||
| Pubmed | Syntenic assignment of human chromosome 1 homologous loci in the bovine. | 3.74e-09 | 14 | 50 | 4 | 8001974 | |
| Pubmed | 6.79e-09 | 16 | 50 | 4 | 2571572 | ||
| Pubmed | 6.79e-09 | 16 | 50 | 4 | 10842072 | ||
| Pubmed | 8.87e-09 | 17 | 50 | 4 | 25410786 | ||
| Pubmed | An amylase/Cre transgene marks the whole endoderm but the primordia of liver and ventral pancreas. | 1.12e-08 | 4 | 50 | 3 | 16786601 | |
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 20939500 | ||
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 2458567 | ||
| Pubmed | Expression of sulfated gp300 and changes in glycosylation during pancreatic development. | 1.12e-08 | 4 | 50 | 3 | 8543783 | |
| Pubmed | 1.14e-08 | 18 | 50 | 4 | 34446743 | ||
| Interaction | AMY2B interactions | 1.60e-06 | 10 | 49 | 3 | int:AMY2B | |
| Cytoband | 1p21 | 5.22e-11 | 24 | 50 | 5 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 1.22e-07 | 107 | 50 | 5 | chr1p21 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 6.75e-06 | 718 | 27 | 8 | 28 | |
| GeneFamily | LIM domain containing | 3.49e-03 | 59 | 27 | 2 | 1218 | |
| Coexpression | BERGER_MBD2_TARGETS | 1.07e-06 | 11 | 50 | 3 | MM905 | |
| Coexpression | LEE_AGING_MUSCLE_UP | 1.13e-06 | 41 | 50 | 4 | MM698 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 5.28e-06 | 60 | 50 | 4 | MM654 | |
| Coexpression | IGLESIAS_E2F_TARGETS_DN | 1.85e-05 | 27 | 50 | 3 | MM643 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_UP | 7.17e-05 | 116 | 50 | 4 | MM1240 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 1.08e-04 | 399 | 50 | 6 | M41172 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 1.18e-04 | 132 | 50 | 4 | MM470 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_UP | 1.51e-04 | 54 | 50 | 3 | MM889 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 1.61e-04 | 143 | 50 | 4 | MM1056 | |
| Coexpression | BORLAK_LIVER_CANCER_EGF_UP | 1.78e-04 | 57 | 50 | 3 | MM527 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_500 | 1.17e-04 | 496 | 48 | 7 | PCBC_EB_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 1.17e-04 | 496 | 48 | 7 | PCBC_EB_blastocyst_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 1.18e-04 | 497 | 48 | 7 | PCBC_EB_fibroblast_500 | |
| ToppCell | Control-T_cells-Tregs|Control / group, cell type (main and fine annotations) | 1.30e-06 | 169 | 50 | 5 | e1e0983f31ec81b3fad5f9c6140d17f03f81a5dc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 184 | 50 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 184 | 50 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 184 | 50 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 2.03e-06 | 185 | 50 | 5 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 2.14e-06 | 187 | 50 | 5 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | Control-T_cells-CD4+_T_cells|Control / group, cell type (main and fine annotations) | 2.31e-06 | 190 | 50 | 5 | 0733be5e54fe15d6d6ea51c154a95258e83f1b92 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-06 | 190 | 50 | 5 | 07ea0578ca0561077557203ae660530f53fc4067 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-06 | 190 | 50 | 5 | 5b4b3eed7aa798bb7e3c5e968c8dc4144e377a5f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.37e-06 | 191 | 50 | 5 | 96a7179a845d3daa046ed71fa45c51255f130a7f | |
| ToppCell | COVID-19-lung-CD4+_Treg|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.37e-06 | 191 | 50 | 5 | 5a4ad5ae5c2dbfb225158cb598ef649c26a48350 | |
| ToppCell | COVID-19-lung-CD4+_Treg|lung / Disease (COVID-19 only), tissue and cell type | 2.37e-06 | 191 | 50 | 5 | 73ea3078c1f55cd47e4d99e77b3ce4ff17549d49 | |
| ToppCell | COVID-19-kidney-T-cells-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.50e-06 | 193 | 50 | 5 | 5b84fa640cf30dea55fde53b810f850ff946d253 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.97e-06 | 200 | 50 | 5 | 9de4d6ebb7e9bee5d811519eb05913ef30f70786 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.81e-06 | 116 | 50 | 4 | f32f7eddfe33adb3b5cf7c34667a481a305c5163 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-3|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-05 | 153 | 50 | 4 | 9d64aadbb4bb28469af1d728457b431e21577429 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-B_cells-CLP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.44e-05 | 164 | 50 | 4 | f5cacd7b2329cb0c7c1696eb4d8f89a4bbd9dda1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-05 | 165 | 50 | 4 | dc570154baed59ed109e5369589448e075ba66a9 | |
| ToppCell | facs-Heart-LV-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 170 | 50 | 4 | 71e5e27c3c4e6cc8dc9b063bd51c21c049f54416 | |
| ToppCell | facs-Heart-LV-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.96e-05 | 170 | 50 | 4 | 255bbbd00d0e17510c5a8c5faa43ed90d887a9de | |
| ToppCell | PSB-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.14e-05 | 172 | 50 | 4 | 57b91bcce3f122f3d3267cf4d3a3ef67842caa9a | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.33e-05 | 174 | 50 | 4 | 61aa89b56ebda0eba1ba675d5f036992967f670f | |
| ToppCell | Control-B_cells|Control / group, cell type (main and fine annotations) | 4.53e-05 | 176 | 50 | 4 | 9125caa27bf790f6b1b960a86c09b4bcb1b58641 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.63e-05 | 177 | 50 | 4 | 7d73643beb007032e757f2611121c4f3027aecf5 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.63e-05 | 177 | 50 | 4 | f1efd9c3074d5635700fe7fbebf3dd0b1e0a84f1 | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.73e-05 | 178 | 50 | 4 | 910f8bea19d335455aba24e6a07b4834b709db5d | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.73e-05 | 178 | 50 | 4 | 7905621f5b2aa55324c5592d1d2fef763a5fa41f | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 178 | 50 | 4 | 5ecbea15efd304057aef826ec2f385997bfaf0c9 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.73e-05 | 178 | 50 | 4 | f914092c20130207193f97c6044ae61a9a440a86 | |
| ToppCell | facs-Lung-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-05 | 178 | 50 | 4 | a9a8567d8fdc0fffd612fee16b5b29ef7b1c9307 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.84e-05 | 179 | 50 | 4 | de3ddc1264e43727be50d69b81cc84a3c91812a2 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.84e-05 | 179 | 50 | 4 | def981e97e3ff9019910c9af3861ca0d08eb0d0f | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.84e-05 | 179 | 50 | 4 | ecea75c568911ff56939c9f67ab901497bd4356c | |
| ToppCell | Control-Lymphocytic_NKT-T_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.84e-05 | 179 | 50 | 4 | d892d9496f1c33e23312092591eb2e968e736f7d | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-1|TCGA-Skin / Sample_Type by Project: Shred V9 | 5.27e-05 | 183 | 50 | 4 | cd00e2cd901df4b3f5f7aed747cc0b47f6d3c811 | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.27e-05 | 183 | 50 | 4 | 59e8d07556390828f7557ba3fd2f7d49851498b7 | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.27e-05 | 183 | 50 | 4 | 2c5707ada3442eb7100a2a5f9438d5a2ac53a9e1 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.38e-05 | 184 | 50 | 4 | 33db879e629821fb75684e60f8f0749cf9623bdd | |
| ToppCell | Control-Lymphocytic_NKT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.50e-05 | 185 | 50 | 4 | 59d68e119f58b35bab36294758f6b2e25fd8f5c0 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.73e-05 | 187 | 50 | 4 | 9d298f43ae81d72091b31aaa6df41046d4aa31c5 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.85e-05 | 188 | 50 | 4 | 71b7599e7e1d63cc0c8518c0501533755951d58f | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.85e-05 | 188 | 50 | 4 | 624426815b789f0f35c327b8c3c0c05ba3aa7d98 | |
| ToppCell | COVID-19-kidney-T-cells-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.85e-05 | 188 | 50 | 4 | 15484c05cb496cd98ed3f79a6134c5cec8f09a4d | |
| ToppCell | LPS_only-Lymphocytic_NKT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.85e-05 | 188 | 50 | 4 | bbe65b1c11c88ab62d8485cfc3a913ff9da89aad | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.97e-05 | 189 | 50 | 4 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-05 | 189 | 50 | 4 | b87d586a9570fa54f3e0c6bd4731c5badcaedae6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-05 | 189 | 50 | 4 | 823d6debd09e440ddf36c54af24a5f20e222a21e | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-05 | 189 | 50 | 4 | 47c2b419b081d5bf75da5e3d9a0e05a70362dfe7 | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 189 | 50 | 4 | 29287525120be2953b76881ba3cfc4379c265e7a | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 189 | 50 | 4 | 7150dad9a92a715487c2d8130fa01b752ea69663 | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.97e-05 | 189 | 50 | 4 | 620d5a71b8cb6288540e2d2d848b9d4d66c1226f | |
| ToppCell | facs-Skin-nan-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 189 | 50 | 4 | 6e4c0effd5192fd00052abc048fdb87a74fb6554 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B-im_lymphoid_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.10e-05 | 190 | 50 | 4 | bee6a438e217b2abd57aef2a80a9fe14a298d223 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.10e-05 | 190 | 50 | 4 | 9b56763d62e1ed50006a5b90b160c5a82aab515b | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.22e-05 | 191 | 50 | 4 | 133864ec1e89f97a82c3bb01d2a3c658397fefaf | |
| ToppCell | COVID-19-lung-CD8+_T_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.22e-05 | 191 | 50 | 4 | 543f8ae07cc2e6950c888115a5ca9445e3c0f618 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-05 | 191 | 50 | 4 | d9506b88d806aadd4c2b9bf86fe994c47799e7f6 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.22e-05 | 191 | 50 | 4 | c7be771543089fc94e5c62fd22f745189642aec3 | |
| ToppCell | Adult-Immune-T_lymphocyte-D175|Adult / Lineage, Cell type, age group and donor | 6.22e-05 | 191 | 50 | 4 | 0b84fd1dc68146d9f72422b102744d2847f5ecb2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-05 | 191 | 50 | 4 | b42c54308abe1241cc38ddce96b9d38d07983891 | |
| ToppCell | COVID-19-T_cells-CD4+_T_cells|COVID-19 / group, cell type (main and fine annotations) | 6.22e-05 | 191 | 50 | 4 | 0646cca78e24aeb6baa9934d3c439b797c567997 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.22e-05 | 191 | 50 | 4 | 9aabbc65430e2233b8f2d3fff9face7807b88b48 | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 6.22e-05 | 191 | 50 | 4 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | PCW_07-8.5-Immune_Lymphocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.22e-05 | 191 | 50 | 4 | 8911b88f70e5deed027177be2e6745b80308616b | |
| ToppCell | PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.35e-05 | 192 | 50 | 4 | 6eadf0f37beae22838e930ad897a9b89e5e12cdb | |
| ToppCell | Adult-Immune-T_lymphocyte|Adult / Lineage, Cell type, age group and donor | 6.48e-05 | 193 | 50 | 4 | 26df0c4c8a2355dd5503fadd07e368eb9a2bf06a | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.48e-05 | 193 | 50 | 4 | 326fd2ce2c4b51e5a38f2a7a09f22f8f0e92735a | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.48e-05 | 193 | 50 | 4 | b9769b45125d2244afe53f9f71c92c04ddccf980 | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.61e-05 | 194 | 50 | 4 | b88cb13c4819e6462bb306d2302b737d3848711f | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.61e-05 | 194 | 50 | 4 | 6385cf2a1529d2e225e407c33da959fccaaca3a4 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.61e-05 | 194 | 50 | 4 | 3d6f2d190dd50804afea299957cc44c2bb756134 | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_B-im_lymphoid_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.61e-05 | 194 | 50 | 4 | 69f7bedf6f0be338e4317c22125e727fb82000fc | |
| ToppCell | human_hepatoblastoma-NK.T_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 6.61e-05 | 194 | 50 | 4 | 997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6 | |
| ToppCell | PCW_13-14-Immune_Lymphocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.61e-05 | 194 | 50 | 4 | 36678999d0c1c5b0aab206fec7a8c36a0f43c56a | |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | 6.61e-05 | 194 | 50 | 4 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 | |
| ToppCell | COVID-19-lung-CD4+_T_cells_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 6.61e-05 | 194 | 50 | 4 | 2a144a1c2d537c8a59aa419206ddd96c23f0aeab | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_B|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.74e-05 | 195 | 50 | 4 | 4570644bcf8bbdfcd70f3cd8840eb94d3df383c8 | |
| ToppCell | COVID-19-kidney-T-cells-1|kidney / Disease (COVID-19 only), tissue and cell type | 7.01e-05 | 197 | 50 | 4 | 9bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e | |
| ToppCell | Control_saline-Hematopoietic_Lymphocytic-Lymphocytic_NK/T|Control_saline / Treatment groups by lineage, cell group, cell type | 7.15e-05 | 198 | 50 | 4 | 9663cf0c8296d3a7b0329cb725ccceeea7849cbc | |
| ToppCell | Control_saline-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells|Control_saline / Treatment groups by lineage, cell group, cell type | 7.15e-05 | 198 | 50 | 4 | 42c855e313d574ef37c2353e4d69809146c391ff | |
| ToppCell | LPS_IL1RA-Hematopoietic_Lymphocytic-Lymphocytic_NK/T|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.15e-05 | 198 | 50 | 4 | a07590c6aa2c889b5d1a0413a6fba5b75bf5d70a | |
| ToppCell | LPS_only-Hematopoietic_Lymphocytic-Lymphocytic_NK/T|LPS_only / Treatment groups by lineage, cell group, cell type | 7.15e-05 | 198 | 50 | 4 | 584dbfeb0bb0358d3757aee56184e91ba35247ae | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.15e-05 | 198 | 50 | 4 | 7608f67959e1cda7b10e57fd3af2f96216ebe7e9 | |
| ToppCell | LPS_only-Hematopoietic_Lymphocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 7.15e-05 | 198 | 50 | 4 | e4e362dca57adba90a2be38dce810857baa2f265 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.15e-05 | 198 | 50 | 4 | 22c412a8d370fabfe4ccfad0b4c24fc965b88b74 | |
| ToppCell | Control_saline-Hematopoietic_Lymphocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 7.15e-05 | 198 | 50 | 4 | d442b35768fe0f75a971784af23400d5d0c7530a | |
| ToppCell | LPS_IL1RA-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.29e-05 | 199 | 50 | 4 | 9382abe4ca553bc4db12e413be921b626e56f2ac | |
| ToppCell | LPS_only-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|LPS_only / Treatment groups by lineage, cell group, cell type | 7.29e-05 | 199 | 50 | 4 | b62a756b5472972156d05051a58671a58bef1f16 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-05 | 199 | 50 | 4 | bc93e5c36ab60b66fb633c954b05d4dc09a7f152 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.29e-05 | 199 | 50 | 4 | c23a53a20487a8abfeb91fa5fc9c06823dd657e9 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-CD4|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-05 | 199 | 50 | 4 | 01ae5ce8e0a1d3bd1cc975b16f53c13bbc13189d | |
| ToppCell | Control_saline-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|Control_saline / Treatment groups by lineage, cell group, cell type | 7.29e-05 | 199 | 50 | 4 | 2d7ebb9642f6fe0afd5e3fdc711ded54b73acd11 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-05 | 199 | 50 | 4 | b947ecaf912d97869f6df32736b8c2b2dd695d66 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-05 | 199 | 50 | 4 | 868ff080f72b6274a84e3ae0ddee4a32ed96472a | |
| ToppCell | LPS_IL1RA-Hematopoietic_Lymphocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.29e-05 | 199 | 50 | 4 | b6a700e101e0418be3ed51ce72a49596bb32d199 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.29e-05 | 199 | 50 | 4 | 0c743e4e88cbd2ca72e5161ca22a3e974b26f9b4 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.29e-05 | 199 | 50 | 4 | 618dc6425bb7b84d3b2de7cf8ecb41549a255718 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-05 | 199 | 50 | 4 | fbdde57dd88656621801e65ee2818251588f3874 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Lymphocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.29e-05 | 199 | 50 | 4 | 5611b9e405a685a7a099d2f2d21dee3a939c2911 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.29e-05 | 199 | 50 | 4 | f44f53a55c8acd4d4769df925c749393b8ecadb7 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 2.49e-13 | 6 | 50 | 5 | CID003083414 | |
| Drug | CNP-G3 | 2.49e-13 | 6 | 50 | 5 | CID003082910 | |
| Drug | R 623 | 2.49e-13 | 6 | 50 | 5 | CID003027594 | |
| Drug | dimethylaminomethylferrocene | 2.49e-13 | 6 | 50 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 2.49e-13 | 6 | 50 | 5 | CID000127364 | |
| Drug | BG5P | 8.70e-13 | 7 | 50 | 5 | CID003082752 | |
| Drug | AC1L5BOU | 8.70e-13 | 7 | 50 | 5 | CID000174858 | |
| Drug | desethylaprophen | 2.32e-12 | 8 | 50 | 5 | CID000163919 | |
| Drug | azintamide | 2.32e-12 | 8 | 50 | 5 | CID000071105 | |
| Drug | alpha-maltosyl fluoride | 5.20e-12 | 9 | 50 | 5 | CID000194237 | |
| Drug | trestatin A | 5.20e-12 | 9 | 50 | 5 | CID003054994 | |
| Drug | AC1LAC07 | 1.04e-11 | 10 | 50 | 5 | CID000485275 | |
| Drug | AC1L3M0Q | 1.04e-11 | 10 | 50 | 5 | CID000118008 | |
| Drug | Glc)4 | 1.04e-11 | 10 | 50 | 5 | CID000189098 | |
| Drug | Ro 20-0083 | 1.04e-11 | 10 | 50 | 5 | CID003082332 | |
| Drug | validamycin D | 1.90e-11 | 11 | 50 | 5 | CID000166726 | |
| Drug | HgI2 | 1.90e-11 | 11 | 50 | 5 | CID000024485 | |
| Drug | 2C KM | 1.90e-11 | 11 | 50 | 5 | CID009549196 | |
| Drug | FG5P | 1.90e-11 | 11 | 50 | 5 | CID000127486 | |
| Drug | CNP-G5 | 1.90e-11 | 11 | 50 | 5 | CID000127309 | |
| Drug | Dembrexine | 2.06e-11 | 4 | 50 | 4 | CID000072009 | |
| Drug | g lw | 2.06e-11 | 4 | 50 | 4 | CID000444139 | |
| Drug | AC1MQT4V | 2.06e-11 | 4 | 50 | 4 | CID003482066 | |
| Drug | beta-santalene | 2.06e-11 | 4 | 50 | 4 | CID000010534 | |
| Drug | 2-nitropropyl acetate | 2.06e-11 | 4 | 50 | 4 | CID013573844 | |
| Drug | N-PMT | 2.06e-11 | 4 | 50 | 4 | CID000194224 | |
| Drug | SAIB-SG | 2.06e-11 | 4 | 50 | 4 | CID002735139 | |
| Drug | azaprophen | 3.25e-11 | 12 | 50 | 5 | CID000129486 | |
| Drug | methyl 1'-epiacarviosin | 5.28e-11 | 13 | 50 | 5 | CID000197426 | |
| Drug | isoacarbose | 5.28e-11 | 13 | 50 | 5 | CID000449165 | |
| Drug | Cyclodextrins | 8.20e-11 | 14 | 50 | 5 | CID000024238 | |
| Drug | terephthaloyl chloride | 8.20e-11 | 14 | 50 | 5 | CID000007488 | |
| Drug | 2-chloro-4-nitrophenol | 8.20e-11 | 14 | 50 | 5 | CID000012074 | |
| Drug | cimicifugic acid A | 1.03e-10 | 5 | 50 | 4 | CID006449879 | |
| Drug | silver perchlorate | 1.03e-10 | 5 | 50 | 4 | CID000024562 | |
| Drug | actinidine | 1.03e-10 | 5 | 50 | 4 | CID000068231 | |
| Drug | Deposiston | 1.03e-10 | 5 | 50 | 4 | CID003080829 | |
| Drug | lunularic acid | 1.03e-10 | 5 | 50 | 4 | CID000161413 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 1.03e-10 | 5 | 50 | 4 | CID010358258 | |
| Drug | himachalene | 1.03e-10 | 5 | 50 | 4 | CID000015095 | |
| Drug | 2TAA | 1.03e-10 | 5 | 50 | 4 | CID000127374 | |
| Drug | AC1L4DZ4 | 1.03e-10 | 5 | 50 | 4 | CID000155287 | |
| Drug | 4-nitrophenylmaltoheptaoside | 1.23e-10 | 15 | 50 | 5 | CID000173254 | |
| Drug | gamma-cyclodextrin | 1.78e-10 | 16 | 50 | 5 | CID000086575 | |
| Drug | Bay e 4609 | 1.78e-10 | 16 | 50 | 5 | CID003085308 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 3.08e-10 | 6 | 50 | 4 | CID009577343 | |
| Drug | Borane dimethylamine complex | 3.08e-10 | 6 | 50 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 3.08e-10 | 6 | 50 | 4 | CID000092801 | |
| Drug | 2-amino-6-picoline | 3.08e-10 | 6 | 50 | 4 | CID000015765 | |
| Drug | phenol blue | 3.08e-10 | 6 | 50 | 4 | CID000075078 | |
| Drug | AC1OAGH8 | 3.08e-10 | 6 | 50 | 4 | CID006857368 | |
| Drug | vermella | 3.08e-10 | 6 | 50 | 4 | CID000203726 | |
| Drug | Gu-4 | 3.08e-10 | 6 | 50 | 4 | CID000448679 | |
| Drug | hymenin | 3.08e-10 | 6 | 50 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 3.08e-10 | 6 | 50 | 4 | CID000011615 | |
| Drug | trimitan | 3.49e-10 | 18 | 50 | 5 | CID000005561 | |
| Drug | aprophen | 3.49e-10 | 18 | 50 | 5 | CID000071128 | |
| Drug | Paramax | 7.17e-10 | 7 | 50 | 4 | CID000156411 | |
| Drug | 3KBG5CNP | 7.17e-10 | 7 | 50 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 7.17e-10 | 7 | 50 | 4 | CID000071762 | |
| Drug | methyl blue | 7.17e-10 | 7 | 50 | 4 | CID011969534 | |
| Drug | amino-methyl | 7.17e-10 | 7 | 50 | 4 | CID000142005 | |
| Drug | AC1L3XPY | 8.24e-10 | 21 | 50 | 5 | CID000124005 | |
| Drug | maltosaccharide | 1.06e-09 | 22 | 50 | 5 | CID005461034 | |
| Drug | boric acid gel | 1.43e-09 | 8 | 50 | 4 | CID003016474 | |
| Drug | AC1NSVJM | 1.43e-09 | 8 | 50 | 4 | CID005317411 | |
| Drug | theodrenaline | 1.43e-09 | 8 | 50 | 4 | CID000071857 | |
| Drug | rhodanile blue | 1.43e-09 | 8 | 50 | 4 | CID000073372 | |
| Drug | N-vinylcaprolactam | 1.43e-09 | 8 | 50 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 1.43e-09 | 8 | 50 | 4 | CID000146692 | |
| Drug | acrinor | 1.43e-09 | 8 | 50 | 4 | CID005489637 | |
| Drug | NSC300622 | 1.43e-09 | 8 | 50 | 4 | CID000028426 | |
| Drug | Panose B | 1.71e-09 | 24 | 50 | 5 | CID000439297 | |
| Drug | CID439354 | 2.14e-09 | 25 | 50 | 5 | CID000439354 | |
| Drug | Atonik | 2.57e-09 | 9 | 50 | 4 | CID000069471 | |
| Drug | GSAD | 2.57e-09 | 9 | 50 | 4 | CID009909127 | |
| Drug | zingiberene | 2.57e-09 | 9 | 50 | 4 | CID000092776 | |
| Drug | H 187 | 2.57e-09 | 9 | 50 | 4 | CID000001742 | |
| Drug | GU-3 | 2.57e-09 | 9 | 50 | 4 | CID000448687 | |
| Drug | mercuric nitrate | 2.57e-09 | 9 | 50 | 4 | CID000024864 | |
| Drug | I ZE | 4.28e-09 | 10 | 50 | 4 | CID009549200 | |
| Drug | eicosa-11,14-dienoic acid | 4.28e-09 | 10 | 50 | 4 | CID000003208 | |
| Drug | trans-cinnamamide | 4.28e-09 | 10 | 50 | 4 | CID000012135 | |
| Drug | CG-120 | 4.28e-09 | 10 | 50 | 4 | CID000171403 | |
| Drug | UDP-pyridoxal | 4.28e-09 | 10 | 50 | 4 | CID000126789 | |
| Drug | naphthalene-1,3,6,8-tetrol | 4.28e-09 | 10 | 50 | 4 | CID000440202 | |
| Drug | N,N'-disalicylidene-1,3-diaminopropane | 5.69e-09 | 30 | 50 | 5 | CID005373003 | |
| Drug | Tempamine | 6.71e-09 | 11 | 50 | 4 | CID000550942 | |
| Drug | L-tert-leucine | 6.71e-09 | 11 | 50 | 4 | CID000164608 | |
| Drug | AMO-1618 | 6.71e-09 | 11 | 50 | 4 | CID000017103 | |
| Drug | AC1L8PXO | 6.71e-09 | 11 | 50 | 4 | CID000430710 | |
| Drug | Folin Marenzi reagent | 8.01e-09 | 32 | 50 | 5 | CID000452313 | |
| Drug | B5-9 | 8.01e-09 | 32 | 50 | 5 | CID003001978 | |
| Drug | N-bromosuccinimide | 8.88e-09 | 69 | 50 | 6 | CID000067184 | |
| Drug | R625 | 9.42e-09 | 33 | 50 | 5 | CID000072375 | |
| Drug | AC1N3UXZ | 9.97e-09 | 3 | 50 | 3 | CID004118625 | |
| Drug | AC1L4W0B | 1.01e-08 | 12 | 50 | 4 | CID000193311 | |
| Drug | chitosan | 1.01e-08 | 12 | 50 | 4 | CID000071853 | |
| Drug | 3-hydr-oxy-2-naphthohydrazide | 1.01e-08 | 12 | 50 | 4 | CID000072699 | |
| Drug | H2folate | 1.01e-08 | 12 | 50 | 4 | CID000168809 | |
| Disease | alpha-amylase 1 measurement | 7.08e-10 | 9 | 47 | 4 | EFO_0801371 | |
| Disease | Graves disease | 2.96e-04 | 81 | 47 | 3 | EFO_0004237 | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 7.25e-04 | 110 | 47 | 3 | EFO_0803335 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.84e-03 | 152 | 47 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | reading | 2.15e-03 | 43 | 47 | 2 | EFO_0005229 | |
| Disease | dyslexia | 2.21e-03 | 162 | 47 | 3 | EFO_0005424 | |
| Disease | response to radiation, hearing loss, response to antineoplastic agent | 2.46e-03 | 46 | 47 | 2 | EFO_0004238, GO_0009314, GO_0097327 | |
| Disease | susceptibility to measles measurement | 2.78e-03 | 49 | 47 | 2 | EFO_0008414 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DFKDFRDSCSSSERT | 981 | Q6ZU80 | |
| VRNFSKFSDCTRAAE | 36 | Q96LK0 | |
| ETCFTRDRKGGFFSS | 641 | P42684 | |
| LFDSFRRDCKADVDT | 51 | Q8IYS8 | |
| SYKLCTRSGNEDEFR | 81 | P0DTE7 | |
| SYKLCTRSGNEDEFR | 81 | P0DTE8 | |
| DRKFLFACETESDQR | 331 | O75689 | |
| SYKLCTRSGNEDEFR | 81 | P0DUB6 | |
| SYKLCTRSGNEDEFR | 81 | P19961 | |
| SFKENSSCGRFDITI | 281 | Q9Y2T2 | |
| DTRQSFCFTRFEAGK | 2011 | Q75N90 | |
| DFETLFTDCTNARRK | 151 | Q96NX9 | |
| SYKLCTRSGNEDEFR | 81 | P04746 | |
| TGRCDFASKNRISSS | 491 | Q8NA72 | |
| CFSGTDRETLSSFKS | 301 | Q9H6A9 | |
| CGTDTNFEVKTRDES | 216 | Q9NRY6 | |
| SCGFERTTRNEKLAA | 426 | Q6ZU52 | |
| RTSDDTSGNRTKCFV | 156 | Q9BXC1 | |
| SRTGFRGKDCSQEDN | 246 | Q9ULB1 | |
| KLAFGCQRSSTSDDD | 11 | Q96MT3 | |
| REGRCSLDTSFSVFK | 921 | Q9NQ11 | |
| SSDERKAFLQFTTGC | 2531 | Q9ULT8 | |
| DSFHRSSFRKCETQL | 2081 | Q8NF50 | |
| DSFSLRRAFCESDKT | 61 | Q14993 | |
| ENGQTKSFRFDCSTS | 211 | Q14CM0 | |
| SVGASCTDDDRLKFN | 1856 | Q8WXX0 | |
| DSFGCRNIFRKTSDS | 496 | P57058 | |
| FSTVDRDRDSYSGNC | 396 | Q8NI99 | |
| KFESCSKEDFRASSS | 231 | Q5SZL2 | |
| RGAFSRQTSTDDECF | 271 | O60759 | |
| EFSDFETSRDKSRQG | 106 | Q9H0W5 | |
| CSSDRSVKIFDVRNG | 31 | P55735 | |
| CAFVTFRSAAERDKA | 111 | Q8IZ69 | |
| TRLRFTKCFSFGSAE | 216 | Q8N4L1 | |
| KRCETEQSTGFNLDF | 1416 | Q4LDE5 | |
| SCCKRRTTDFSDFLS | 41 | Q9UHD1 | |
| QESRTFCKEEFGLTS | 3191 | A4UGR9 | |
| EECGKAFRTNSDFTV | 811 | Q9P2J8 | |
| SECGRGFSEKSSFIR | 356 | Q6P1L6 | |
| RRDFCRESAQKDSGS | 176 | Q53GI3 | |
| GSEISSIDEFCRKFR | 86 | Q9UK41 | |
| RRNSSDSFCRNSEDK | 626 | Q96N46 | |
| FEGCDRRFANSSDRK | 336 | Q15915 | |
| EGSDSSETFRKCFRQ | 36 | Q63HK3 | |
| EECGKTFNRFSTLTT | 261 | Q03923 | |
| RKFTFECSDGTSFAE | 1506 | O75093 | |
| ERSFECTECGRVFSQ | 551 | P17021 | |
| QEKSFRCDTCSNSFG | 311 | Q2VY69 | |
| FKESSAAEAFRCRSI | 966 | P49815 | |
| SRKDGEASSRCSGEF | 361 | P57075 |